BNTX

BioNTech SE ADR

99.32

Sep 24 • 12:50 PM ET +0.86 (0.87%)

Healthcare Biotechnology Germany Large NASD

Peers: MRNA ALNY ARGX REGN ONC VRTX BMRN BIIB AMGN GILD

| Held by: FBT IBB FNDF SPDW IDNA BBH BBEU QQQJ IALT BBIN

Index	-
Market Cap	24.95B
Enterprise Value	8.42B
Income	-1.97B
Sales	3.09B
Book/sh	80.82
Cash/sh	67.25
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	Jun 02, 2022
Dividend Gr. 3/5Y	- -
Payout	-
Employees	7807
IPO	Oct 10, 2019

P/E	-
Forward P/E	-
PEG	-
P/S	8.07
P/B	1.23
P/C	1.48
P/FCF	52.03
EV/EBITDA	-
EV/Sales	2.72
Quick Ratio	7.80
Current Ratio	7.85
Debt/Eq	0.02
LT Debt/Eq	0.01
Option/Short	Yes / Yes

EPS (ttm)	-7.85
EPS next Y	-6.47
EPS next Q	0.85
EPS this Y	-19.70%
EPS next Y	-1.12%
EPS next 5Y	6.12%
EPS past 3/5Y	- -
Sales past 3/5Y	-43.74% 42.57%
EPS Y/Y TTM	-395.95%
Sales Y/Y TTM	-1.05%
EPS Q/Q	-108.42%
Sales Q/Q	-58.46%
Earnings	Aug 04 BMO
EPS/Sales Surpr.	-54.07% -33.16%

Insider Own	0.43%
Insider Trans	-31.56%
Inst Own	19.55%
Inst Trans	-0.20%
ROA	-8.08%
ROE	-9.35%
ROIC	-9.54%
Gross Margin	63.87%
Oper. Margin	-37.57%
Profit Margin	-63.55%
SMA20	-0.69%
SMA50	1.57%
SMA200	1.73%
Trades

Shs Outstand	251.20M
Shs Float	250.13M
Short Float	0.92%
Short Ratio	1.98
Short Interest	2.30M
52W High	124.00 -19.90%
52W Low	79.52 24.90%
Volatility	3.32% 2.91%
ATR (14)	3.64
RSI (14)	49.99
Beta	1.24
Rel Volume	0.54
Avg Volume	1.16M
Volume	340,801

Perf Week	0.67%
Perf Month	-12.92%
Perf Quarter	10.36%
Perf Half Y	11.88%
Perf YTD	4.33%
Perf Year	-0.43%
Perf 3Y	-5.08%
Perf 5Y	-69.82%
Perf 10Y	-
Recom	1.76
Target Price	118.06
Prev Close	98.46
Price	99.32
Change %	0.87%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-08-26	Downgrade	BMO Capital Markets	Outperform → Market Perform	$105
May-27-26	Upgrade	UBS	Neutral → Buy	$135
May-22-26	Initiated	Bernstein	Mkt Perform	$96
Feb-02-26	Downgrade	Leerink Partners	Outperform → Market Perform	$113
Jan-16-26	Upgrade	Goldman	Neutral → Buy	$142
Jun-05-25	Reiterated	H.C. Wainwright	Buy	$134 → $145
May-29-25	Initiated	Goldman	Neutral	$110
Mar-13-25	Initiated	Citigroup	Buy	$145
Jan-10-25	Initiated	Truist	Buy	$172
Dec-11-24	Initiated	Wells Fargo	Overweight	$170
Dec-02-24	Reiterated	BMO Capital Markets	Outperform
Nov-19-24	Upgrade	Evercore ISI	In-line → Outperform	$110 → $125
Nov-19-24	Initiated	Berenberg	Buy	$130
Nov-08-24	Upgrade	Goldman	Neutral → Buy	$90 → $137
Sep-24-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$93 → $145
Sep-17-24	Upgrade	Jefferies	Hold → Buy	$96 → $150
Sep-16-24	Upgrade	JP Morgan	Underweight → Neutral	$91 → $125
Aug-07-24	Upgrade	Deutsche Bank	Hold → Buy	$95
Aug-02-24	Upgrade	HSBC Securities	Hold → Buy
May-14-24	Initiated	Evercore ISI	In-line	$100

Show Previous Ratings

Sep-23-26 12:53PM	Moderna CEO's Surprising Comment Gives Clues About Where Drugmaker Is Going Next (Barrons.com)
Sep-21-26 01:12PM	Moderna Stock Jumps. Its mRNA Cancer Vaccine Is Getting Ready for Its Next Big Test. (Barrons.com)
Sep-14-26 10:12AM	BioNTech Shares Rise 6.4% After Updated Gotistobart Lung Cancer Trial Data (InvestorsHub)
04:00AM	BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients (GlobeNewswire)
Sep-08-26 07:28AM	BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts (Investing.com)
06:18AM	Loading…
06:18AM	BioNTech Shares Fall After BMO Downgrade and Price Target Cut (InvestorsHub)
Aug-28-26 02:02PM	BioNTech Kills a Cancer Trial Roche Helped Build (GuruFocus.com) -8.37%
10:46AM	BioNTech Stock Falls on Cancer Vaccine Setback (Barrons.com)
10:09AM	BioNTech drops 10% on mRNA trial failure, highlighting Moderna contrast (Investing.com)
Aug-27-26 04:30PM	Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine (Business Wire)
Aug-21-26 02:54PM	Can mRNA Cure Cancer? Inside the Pipeline Risks for Biotech's Biggest Players (Barrons.com) +5.12%
01:44PM	Why Moderna's mRNA Cancer Drug Hype Has Gone Too Far (Barrons.com)
Aug-20-26 12:43PM	Moderna's Cancer Vaccine: Are Investors Putting The Cart Before The Horse? (Investor's Business Daily)
05:30AM	BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026 (GlobeNewswire)
Aug-19-26 03:38PM	Moderna's cancer-vaccine breakthrough drives broad biopharma stock rally (MarketWatch) +21.96%
02:54PM	Loading…
02:54PM	BioNTech Stock Surges 20% on Moderna Cancer Vaccine Win. Why the Gains Could Fade. (Barrons.com)
08:28AM	Moderna stock is soaring in premarket after encouraging trial of cancer vaccine (MarketWatch)
Aug-04-26 03:01PM	BioNTech SE (BNTX) (Q2 2026) Earnings Call Highlights: Strong Pipeline Progress Offsets Revenue ... (GuruFocus.com)
07:12AM	Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings (Barrons.com)
06:45AM	BioNTech Announces Second Quarter 2026 Financial Results and Corporate Update (GlobeNewswire)
Aug-03-26 05:00AM	BioNTech Announces Appointment of Guido Oelkers to Management Board as Chief Executive Officer (GlobeNewswire)
Jul-30-26 08:40AM	EU greenlights Pfizer and BioNTech's new COVID vaccine (InvestorsHub)
Jul-29-26 04:30PM	European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union (Business Wire)
Jul-21-26 06:45AM	BioNTech to Report Second Quarter 2026 Financial Results and Corporate Update on August 4, 2026 (GlobeNewswire)
Jul-07-26 03:22PM	Former Pfizer Building Is Crumbling-Just as the Stock Has (Barrons.com)
Jun-18-26 10:34AM	VERAXA Unveils Cancer Therapy Platform, Sparks Partnering Talks at BIO 2026 (Exec Edge)
May-30-26 02:15PM	Global Data for BioNTech and Bristol Myers Squibb's PD-L1xVEGF-A Bispecific Pumitamig Shows Encouraging Efficacy in Patients with Non-Small Cell Lung Cancer in ROSETTA Lung-02 Trial (GlobeNewswire)
May-27-26 11:07AM	This Biotech Stock Is Stuck in the Red. Its Cancer Portfolio Is About to Change the Narrative. (Barrons.com)
May-22-26 05:00AM	BioNTech to Showcase Progress Across Late-Stage Oncology Pipeline at the 2026 ASCO Annual Meeting (GlobeNewswire)
May-20-26 03:29PM	JPMorgan sees biotech sector at inflection point, resumes coverage on 14 Firms (Investing.com)
04:15PM	Loading…
May-15-26 04:15PM	BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2026 (GlobeNewswire)
May-07-26 06:45AM	BioNTech Announces New ADS Repurchase Program (GlobeNewswire)
May-05-26 09:54AM	BioNTech to Slash 25% of Workforce as Losses Widen. The Stock Falls. (Barrons.com)
07:26AM	BioNTech to Close Sites, Cut Quarter of Workforce in Savings Push (The Wall Street Journal)
06:45AM	BioNTech Announces First Quarter 2026 Financial Results and Corporate Update (GlobeNewswire)
Apr-21-26 06:45AM	BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026 (GlobeNewswire) +6.09%
Apr-11-26 07:00AM	BioNTech and DualityBio's Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer (GlobeNewswire)
Mar-24-26 06:45AM	BioNTech Clinical Data at ELCC 2026 Highlight Potential of Differentiated Late-Stage Portfolio in Lung Cancer (GlobeNewswire)
Mar-16-26 04:03PM	Covid Vaccine Maker BioNTech Offers Cheap Biotech Play Given Huge Cash Reserves (Barrons.com)
Mar-15-26 05:05PM	Man's dog was riddled with tumors and dying. He used ChatGPT to design a custom cancer vaccine, stunning researchers (Moneywise)
Mar-11-26 05:55AM	BioNTech price target lowered to $130 from $145 at Citi (TipRanks) +8.28%
Mar-10-26 04:42PM	BioNTech Stock Plunges as Founders Leave. Should You Buy the Dip in BNTX Here? (Barchart) -17.88%
04:20PM	BioNTech Cofounders To Step Down. Stock Crumbles. (Investor's Business Daily)
03:39PM	BioNTech Stock Tanks As Outlook, Founder Exit Rattle Bulls (Benzinga)
03:00PM	BioNTech SE (BNTX) Q4 2025 Earnings Call Highlights: Strategic Advances Amidst Revenue Challenges (GuruFocus.com)
11:01AM	Kohl's Q4 sales miss, EV maker NIO reports first quarterly profit (Yahoo Finance Video)
10:01AM	BioNTech Tumbles as Founding Duo Plan Leave to Start New Firm (Bloomberg)
09:24AM	BioNTech Reports Earnings. That's Not Why the Stock Is Down 17%. (Barrons.com)
08:40AM	BioNTech Stock Tumbles As Co-Founders Pivot To New MRNA Venture (Benzinga)
07:40AM	Scientists behind COVID-19 vaccine will depart BioNTech (MarketWatch)
07:18AM	BioNTech Plunges as Drugmaker Swings to a Loss. More Than Earnings Are Weighing on the Stock. (Barrons.com)
06:50AM	BioNTech Cofounders to Leave to Form New Company (The Wall Street Journal)
06:45AM	BioNTech Announces Fourth Quarter and Full Year 2025 Financial Results and Corporate Update (GlobeNewswire)
06:33AM	BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA Innovations in Co-Founders-Led New Company as BioNTech Advances Toward Becoming a Multi-Product Company by 2030 (GlobeNewswire)
Mar-09-26 04:17PM	Oracle, Ulta, Adobe, More Stocks With Earnings This Week (Benzinga)
Mar-05-26 12:37PM	Is BioNTech SE (BNTX) A Good Stock To Buy Now? (Insider Monkey)
Mar-04-26 08:14AM	Moderna's $950 Million Settlement Clears Legal Overhang, Stock Soars (Benzinga)
Feb-25-26 09:00AM	Immuno-Oncology Investments Accelerate as Pipeline Catalysts Multiply in 2026 (PR Newswire)
Feb-24-26 06:45AM	BioNTech to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on March 10, 2026 (GlobeNewswire)
Feb-22-26 09:05AM	Moderna, Coinbase, And Global Payments Are Among the Top 10 Large-Cap Gainers Last Week (Feb. 16-Feb. 20): Are the Others in Your Portfolio? (Benzinga)
Feb-20-26 11:02AM	Moderna Faces Lawsuit From BioNTech Over Next-Generation COVID-19 Shot (Benzinga)
Feb-19-26 03:43AM	BioNTech SE (BNTX) Rallying on Solid Oncology Strategy (Insider Monkey)
Feb-18-26 11:20AM	Moderna stock surges as FDA reverses course, agrees to review new flu shot (Yahoo Finance)
Feb-09-26 10:29AM	BMY Up 7.6% Post Q4 Earnings: Should You Buy, Sell or Hold the Stock? (Zacks)
Feb-03-26 11:32AM	Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data (Zacks)
Feb-02-26 09:47AM	Palantir upgraded, Best Buy downgraded: Wall Street's top analyst calls (The Fly)
08:10AM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q4 Earnings? (Zacks)
Jan-31-26 06:09AM	Goldman Sachs Picks 2 Stocks That Let Investors Buy the Dip or Ride the Momentum (TipRanks)
Jan-30-26 08:49AM	Will BMY's Oncology Collaborations Drive Its Next Growth Phase? (Zacks)
07:58AM	Should You Buy, Sell or Hold Pfizer Stock Ahead of Q4 Earnings? (Zacks)
02:07AM	Goldman Sachs Highlights BioNTech's (BNTX) Immuno-Oncology and ADC Pipeline (Insider Monkey)
Jan-28-26 09:15AM	Late-Stage Breakthroughs: How 2026's Top Clinical Platforms Are Redefining Cancer Treatment (PR Newswire)
09:13AM	BioNTech SE (BNTX): A Bull Case Theory (Insider Monkey)
08:00AM	BioNTech Announces Appointment of Kylie Jimenez to Management Board as Chief People Officer (GlobeNewswire)
Jan-27-26 01:35PM	2 Biotech Stocks Set to Rebound in 2026 (Motley Fool)
05:38AM	Pfizers CEO on leading after a moonshotand making deals with Trump (Fortune)
05:32AM	What Are Wall Street Analysts' Target Price for Pfizer Stock? (Barchart)
Jan-22-26 10:28AM	BioNTech (BNTX) Soars 11.8%: Is Further Upside Left in the Stock? (Zacks)
01:03AM	Vaccine makers feel a chill as US Health Secretary Kennedy's rhetoric becomes reality (Reuters)
Jan-20-26 01:41PM	BMY vs GSK: Which Biopharma Giant Has Better Prospects for Now? (Zacks)
Jan-19-26 09:01AM	What to Expect From Pfizer's Non-Oncology Business in Q4? (Zacks)
Jan-16-26 09:32AM	Seagate upgraded, Tractor Supply downgraded: Wall Street's top analyst calls (The Fly)
Jan-14-26 07:59AM	JPM26: BioNTech gears up for multiproduct oncology status by 2030 (Pharmaceutical Technology)
04:04AM	BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan (MarketBeat)
Jan-12-26 06:45AM	BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-09-26 09:16AM	BMY Rallies 17.3% in Six Months: Buy, Sell or Hold the Stock? (Zacks)
Dec-23-25 12:53AM	BioNTech SE (BNTX) Closes the Acquisition of CureVac N.V. (Insider Monkey)
Dec-18-25 04:45AM	BioNTech Closes Acquisition of CureVac N.V. Including Subsequent Offering Period to Strengthen its Unique Position in the mRNA Field (GlobeNewswire)
Dec-15-25 09:00AM	GeoVax Announces British Journal of Haematology Publication Highlighting Superior T-Cell Responses of GEO-CM04S1 in CLL Patients (NewMediaWire)
Dec-11-25 02:03PM	Moderna Sounds the Alarm: Is China About to Seize the Biotech Crown from the U.S.? (GuruFocus.com)
07:44AM	BioNTech SE (BNTX) is a Buy on Lung Cancer Treatment Prospects: Clear Street (Insider Monkey)
Dec-09-25 07:00AM	BioNTech and Bristol Myers Squibb Present First Global Phase 2 Data for PD-L1xVEGF-A Bispecific Antibody Pumitamig Showing Encouraging Efficacy in Advanced Triple-Negative Breast Cancer (GlobeNewswire)
Dec-06-25 03:30PM	BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer (GlobeNewswire)
Dec-03-25 09:01AM	BioNTech Achieves Minimum Condition in CureVac Exchange Offer (GlobeNewswire)
Dec-02-25 09:40AM	Vaccine Stocks Fall After FDA Plans to Impose Stricter Vaccine Rules (Zacks)
Dec-01-25 04:41PM	Moderna Slammed By 'Fear, Confusion' After FDA Alleges Covid Shots Killed 10 (Investor's Business Daily) -5.58%
03:05PM	FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks (Investopedia)
12:35PM	Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men (MarketWatch)
12:24PM	Nvidia's Synopsys investment, Disney stock pops on Zootopia 2 (Yahoo Finance Video)
12:09PM	Vaccine makers fall on FDA memo, Bally's wins bid for NYC casino (Yahoo Finance Video)

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

Co-FounderDr. Ugur Sahin M.D.

Co-FounderDr. Ozlem Tureci M.D.

CFO & Member of Management BoardMr. Ramon Zapata-Gomez

MDDr. Sierk Potting Ph.D.

Chief Legal & Business Officer and Member of the Management BoardDr. James Timothy Patrick Ryan Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sahin Ugur	Chief Executive Officer	Sep 22 '26	Sale	100.72	46,000	4,633,037	410,209	Sep 22 05:04 PM
Sahin Ugur	Chief Executive Officer	Sep 21 '26	Sale	97.81	33,000	3,227,720	456,209	Sep 22 05:04 PM
Sahin Ugur	Chief Executive Officer	Sep 17 '26	Sale	98.60	34,000	3,352,342	519,209	Sep 18 04:41 PM
Sahin Ugur	Chief Executive Officer	Sep 18 '26	Sale	96.22	30,000	2,886,729	489,209	Sep 18 04:41 PM
Sahin Ugur	Chief Executive Officer	Sep 15 '26	Sale	96.49	34,000	3,280,636	568,209	Sep 16 04:46 PM
Sahin Ugur	Chief Executive Officer	Sep 16 '26	Sale	96.09	15,000	1,441,340	553,209	Sep 16 04:46 PM
Sahin Ugur	Chief Executive Officer	Sep 11 '26	Sale	96.93	45,000	4,362,021	643,209	Sep 14 04:50 PM
Sahin Ugur	Chief Executive Officer	Sep 14 '26	Sale	99.45	41,000	4,077,315	602,209	Sep 14 04:50 PM
Sahin Ugur	Chief Executive Officer	Sep 10 '26	Sale	96.31	20,500	1,974,287	688,209	Sep 11 05:18 PM
Sahin Ugur	Chief Executive Officer	Sep 08 '26	Sale	99.20	37,000	3,670,518	744,709	Sep 09 05:29 PM
Sahin Ugur	Chief Executive Officer	Sep 09 '26	Sale	97.78	36,000	3,520,145	708,709	Sep 09 05:29 PM
Sahin Ugur	Chief Executive Officer	Sep 03 '26	Sale	102.85	45,000	4,628,232	813,209	Sep 08 04:10 PM
Sahin Ugur	Chief Executive Officer	Sep 04 '26	Sale	103.52	31,500	3,260,823	781,709	Sep 08 04:10 PM
Medine GmbH	Officer	Sep 03 '26	Proposed Sale	103.81	858,209	89,090,676		Sep 03 08:03 AM
Medine GmbH	Officer	May 13 '26	Proposed Sale	93.66	858,209	80,379,855		May 12 06:56 PM
Poetting Sierk	Chief Operating Officer	Apr 22 '26	Sale	110.56	50,000	5,527,960	399,387	Apr 23 04:02 PM
Poetting Sierk	Officer	Mar 11 '26	Proposed Sale	83.89	150,000	12,583,500		Mar 11 08:02 AM
Medine GmbH	Officer	Feb 12 '26	Proposed Sale	109.38	858,209	93,870,900		Feb 12 08:17 AM
Tureci Ozlem	Officer	Nov 28 '25	Proposed Sale	102.70	123,331	12,666,094		Nov 28 07:10 AM
Medine GmbH	Officer	Nov 13 '25	Proposed Sale	111.70	1,114,130	124,448,321		Nov 13 08:23 AM
Jeggle Helmut Wolfgang	Director	Nov 05 '25	Proposed Sale	103.43	150,000	15,514,500		Nov 05 04:52 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BNTX

BioNTech SE ADR

Upgrade your Finviz experience